Journal
TROPICAL MEDICINE AND INFECTIOUS DISEASE
Volume 8, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/tropicalmed8050245
Keywords
Chagas disease; resistant triatomines; entomopathogenic fungi; microencapsulated; bioinsecticide
Categories
Ask authors/readers for more resources
In this study, the bioinsecticidal activity and residual effect of a microencapsulation formulation of an entomopathogenic fungus (B. bassiana) were tested against pyrethroid-resistant Triatoma infestans nymphs. The microencapsulated fungus showed higher nymph mortality compared to the non-microencapsulated fungus and maintained conidial viability throughout the evaluation period. Alginate microencapsulation could serve as a cost-effective method for developing a bioinsecticide to reduce Chagas disease transmission.
The blood-sucking bug Triatoma infestans is the main Chagas disease vector in the Southern Cone of Latin America. Populations resistant to pyrethroid insecticides have been detected in the early 2000s and then expanded to the endemic area of northern Salta province, Argentina. In this context, the entomopathogenic fungus Beauveria bassiana has been shown to be pathogenic to pyrethroid-resistant T. infestans. In this study, both the bioinsecticidal activity and the residual effect of an alginate-based microencapsulation of a native strain of B. bassiana (Bb-C001) were tested under semi-field conditions against pyrethroid-resistant T. infestans nymphs. Fungal microencapsulated formulation caused higher nymph mortality than the unmicroencapsulated fungus and contributed to maintaining the conidial viability throughout the period evaluated under the tested conditions. These results suggest that alginate microencapsulation is an effective, simple, low-cost method that could be incorporated into the formulation of a bioinsecticide as a strategy to reduce the vector transmission of Chagas disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available